Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- Swansea University · Body governed by public law
- Supplier
- Bruker AXS SAS
- Value
- £270,000
- Procedure
- Open procedure
- Sector
- Laboratory & precision equipment · Microscopes (CPV 38510000)
- Region
- Wales
- Official notice
- 004621-2021 on Find a Tender
- Timeline
-
- Contract date25 Feb 2021
- Published8 Mar 2021Published 11 days after the contract date
Description
The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6m project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer. The purchase will include instrumentation to hybrid with the Zeiss 510 confocal capacity currently on site and will include provision to image and force characterise the interactions between target compounds and their intended drug delivery moieties/target cells, using all available AFM data channels (specifically height and mechanical z scale information).
About the supplier
Bruker AXS SAS: every public contract they have won.